Skyline Medical Inc. (SKLN) Reaches $0.92 Yearly Low; Axt (AXTI) Shorts Up By 4.44%

January 5, 2018 - By Vivian Park

Axt Incorporated (NASDAQ:AXTI) had an increase of 4.44% in short interest. AXTI’s SI was 1.56M shares in January as released by FINRA. Its up 4.44% from 1.50 million shares previously. With 647,700 avg volume, 2 days are for Axt Incorporated (NASDAQ:AXTI)’s short sellers to cover AXTI’s short positions. The SI to Axt Incorporated’s float is 4.98%. The stock decreased 0.28% or $0.02 during the last trading session, reaching $8.88. About 34,661 shares traded. AXT, Inc. (NASDAQ:AXTI) has risen 115.17% since January 5, 2017 and is uptrending. It has outperformed by 98.47% the S&P500.

The stock of Skyline Medical Inc. (NASDAQ:SKLN) hit a new 52-week low and has $0.86 target or 6.00% below today’s $0.92 share price. The 5 months bearish chart indicates high risk for the $5.75 million company. The 1-year low was reported on Jan, 5 by If the $0.86 price target is reached, the company will be worth $344,940 less. The stock decreased 7.58% or $0.075 during the last trading session, reaching $0.915. About 1.45 million shares traded or 203.40% up from the average. Skyline Medical Inc. (NASDAQ:SKLN) has declined 52.09% since January 5, 2017 and is downtrending. It has underperformed by 68.79% the S&P500.

AXT, Inc. designs, develops, manufactures, and distributes compound and single element semiconductor substrates. The company has market cap of $342.29 million. The firm makes its semiconductor substrates using its proprietary vertical gradient freeze technology. It has a 35.79 P/E ratio. It offers semi-insulating gallium with arsenic substrates, which are used for applications in power amplifiers for wireless devices, and transistors and solar cells for drones.

Among 7 analysts covering AXT Inc (NASDAQ:AXTI), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. AXT Inc had 14 analyst reports since December 9, 2015 according to SRatingsIntel. The rating was upgraded by Craig Hallum to “Buy” on Tuesday, May 3. Northland Capital maintained it with “Buy” rating and $11.0 target in Thursday, October 26 report. The rating was maintained by Needham on Thursday, February 23 with “Buy”. The firm has “Buy” rating given on Thursday, October 27 by Needham. The rating was maintained by Needham on Thursday, October 26 with “Buy”. The firm has “Neutral” rating given on Thursday, October 26 by B. Riley & Co. The rating was maintained by Northland Capital on Wednesday, September 6 with “Buy”. The firm has “Buy” rating given on Friday, June 16 by Dougherty. The rating was downgraded by B. Riley & Co on Friday, March 17 to “Neutral”. As per Monday, February 13, the company rating was initiated by Dougherty & Company.

Since July 31, 2017, it had 0 insider buys, and 2 sales for $872,082 activity. Shares for $792,882 were sold by YOUNG MORRIS S on Monday, July 31. $79,200 worth of AXT, Inc. (NASDAQ:AXTI) was sold by CHANG DAVID C on Tuesday, August 1.

Investors sentiment decreased to 1.21 in 2017 Q3. Its down 0.28, from 1.49 in 2017Q2. It worsened, as 14 investors sold AXT, Inc. shares while 25 reduced holdings. 20 funds opened positions while 27 raised stakes. 23.45 million shares or 1.37% less from 23.77 million shares in 2017Q2 were reported. Qs Investors Limited Liability Corp invested in 1,160 shares or 0% of the stock. 164,607 are owned by Parametric Port Assocs Ltd Liability Co. Dimensional Fund Advisors L P holds 0.01% or 3.08 million shares. Nationwide Fund holds 0% of its portfolio in AXT, Inc. (NASDAQ:AXTI) for 30,965 shares. Moreover, Essex Invest Mngmt Commerce Ltd has 0.41% invested in AXT, Inc. (NASDAQ:AXTI) for 328,121 shares. 3,632 are owned by Bnp Paribas Arbitrage. Herald Mngmt Ltd invested 0.44% of its portfolio in AXT, Inc. (NASDAQ:AXTI). Credit Suisse Ag reported 25,883 shares or 0% of all its holdings. Guggenheim Llc reported 11,782 shares stake. Goldman Sachs Group stated it has 28,436 shares or 0% of all its holdings. First Manhattan Co has 5,000 shares. Blackrock holds 2.55 million shares. Citigroup holds 0% or 123 shares in its portfolio. Ameritas Prns Inc has 3,267 shares for 0% of their portfolio. Panagora Asset Mngmt invested 0% in AXT, Inc. (NASDAQ:AXTI).

Skyline Medical Inc., a medical device company, makes environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care in the United States. The company has market cap of $5.75 million. It offers the STREAMWAY Fluid Waste Management System that suctions surgical waste fluid from the patient using standard surgical tubing. It currently has negative earnings. The companyÂ’s system replaces the manual process of collecting fluids in canisters, and transporting and dumping in sinks outside of the operating room.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.